Marie-kristin Von Wahlde

Muenster, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Re-excision in Ductal Carcinoma In Situ Is Not Associated With Improved Local Control: A Retrospective Cohort Study.

Re-excision in Ductal Carcinoma In Situ Is Not Associated With Improved Local Control: A Retrospective Cohort Study.

Journal: Clinical breast cancer

Published: June 18, 2026

Outbreak of MRSA in a Gynecology/Obstetrics Department during the COVID-19 Pandemic: A Cautionary Tale.

Outbreak of MRSA in a Gynecology/Obstetrics Department during the COVID-19 Pandemic: A Cautionary Tale.

Journal: Microorganisms

Published: February 22, 2022

Establishment of a 3D co-culture model to investigate the role of primary fibroblasts in ductal carcinoma in situ of the breast.

Establishment of a 3D co-culture model to investigate the role of primary fibroblasts in ductal carcinoma in situ of the breast.

Journal: Cancer reports (Hoboken, N.J.)

Published: January 07, 2022

The heparan sulphate proteoglycan Syndecan-1 (CD138) regulates tumour progression in a 3D model of ductal carcinoma in situ of the breast.

The heparan sulphate proteoglycan Syndecan-1 (CD138) regulates tumour progression in a 3D model of ductal carcinoma in situ of the breast.

Journal: IUBMB life

Published: December 01, 2021

Collagen I triggers directional migration, invasion and matrix remodeling of stroma cells in a 3D spheroid model of endometriosis.

Collagen I triggers directional migration, invasion and matrix remodeling of stroma cells in a 3D spheroid model of endometriosis.

Journal: Scientific reports

Published: October 18, 2019

Ribociclib in Breast Cancer Brain Metastases: A Case Report.

Ribociclib in Breast Cancer Brain Metastases: A Case Report.

Journal: Breast care (Basel, Switzerland)

Published: September 19, 2019

Correlation between SFRP1 expression and clinicopathological parameters in patients with triple-negative breast cancer.

Correlation between SFRP1 expression and clinicopathological parameters in patients with triple-negative breast cancer.

Journal: Future oncology (London, England)

Published: May 30, 2019

Increased epigenetic age in normal breast tissue from luminal breast cancer patients.

Increased epigenetic age in normal breast tissue from luminal breast cancer patients.

Journal: Clinical epigenetics

Published: December 28, 2017

Tumor-Infiltrating Lymphocytes and PD-L1 Expression in Pre- and Posttreatment Breast Cancers in the SWOG S0800 Phase II Neoadjuvant Chemotherapy Trial.

Tumor-Infiltrating Lymphocytes and PD-L1 Expression in Pre- and Posttreatment Breast Cancers in the SWOG S0800 Phase II Neoadjuvant Chemotherapy Trial.

Journal: Molecular cancer therapeutics

Published: October 16, 2017

Reverse engineering of triple-negative breast cancer cells for targeted treatment.

Reverse engineering of triple-negative breast cancer cells for targeted treatment.

Journal: Maturitas

Published: August 25, 2017

Intratumor Heterogeneity of Homologous Recombination Deficiency in Primary Breast Cancer.

Intratumor Heterogeneity of Homologous Recombination Deficiency in Primary Breast Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: April 15, 2016

The anti-androgen drug dutasteride renders triple negative breast cancer cells more sensitive to chemotherapy via inhibition of HIF-1α-/VEGF-signaling.

The anti-androgen drug dutasteride renders triple negative breast cancer cells more sensitive to chemotherapy via inhibition of HIF-1α-/VEGF-signaling.

Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology

Published: October 31, 2014

Showing 1-12 of 12

Last Updated: 09/26/2026